This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korin, Y. D.
Right arrow Articles by Zack, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korin, Y. D.
Right arrow Articles by Zack, J. A.

 Previous Article  |  Next Article 

Journal of Virology, August 1999, p. 6526-6532, Vol. 73, No. 8
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Nonproductive Human Immunodeficiency Virus Type 1 Infection in Nucleoside-Treated G0 Lymphocytes

Yael D. Korin1,2 and Jerome A. Zack2,3,*

Department of Pathology and Laboratory Medicine,1 AIDS Institute,2 and Division of Hematology-Oncology, Department of Medicine, and Department of Microbiology and Molecular Genetics, School of Medicine,3 University of California, Los Angeles, Los Angeles, California

Received 19 January 1999/Accepted 26 April 1999

Productive infection by human immunodeficiency virus type 1 (HIV-1) requires the activation of target cells. Infection of quiescent peripheral CD4 lymphocytes by HIV-1 results in incomplete, labile, reverse transcripts. We have previously identified G1b as the cell cycle stage required for the optimal completion of the reverse transcription process in T lymphocytes. However, the mechanism(s) involved in the blockage of reverse transcription remains undefined. In this study we investigated whether nucleotide levels influence viral reverse transcription in G0 cells. For this purpose the role of the enzyme ribonucleotide reductase was bypassed, by adding exogenous deoxyribonucleosides to highly purified T cells in the G0 or the G1a phase of the cell cycle. Our data showed a significant increase in the efficiency of the reverse transcription process following the addition of the deoxyribonucleosides. To define the stability and functionality of these full reverse transcripts, we used an HIV-1 reporter virus that expresses the murine heat-stable antigen on the surfaces of infected cells. Following activation of infected quiescent cells treated with exogenous nucleosides, no increased rescue of productive infection was seen. Thus, in addition to failure to complete reverse transcription, there was an additional nonreversible blockage of productive infection in quiescent T cells. These experiments have important relevance in the gene therapy arena, in terms of improving the ability of lentivirus vectors to enter metabolically inactive cells, such as hematopoietic stem cells.


* Corresponding author. Mailing address: Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90095-1678. Phone: (310) 794-7765. Fax: (310) 825-6192. E-mail: jzack{at}ucla.edu.


Journal of Virology, August 1999, p. 6526-6532, Vol. 73, No. 8
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Agosto, L. M., Yu, J. J., Liszewski, M. K., Baytop, C., Korokhov, N., Humeau, L. M., O'Doherty, U. (2009). The CXCR4-Tropic Human Immunodeficiency Virus Envelope Promotes More-Efficient Gene Delivery to Resting CD4+ T Cells than the Vesicular Stomatitis Virus Glycoprotein G Envelope. J. Virol. 83: 8153-8162 [Abstract] [Full Text]  
  • Arfi, V., Lienard, J., Nguyen, X.-N., Berger, G., Rigal, D., Darlix, J.-L., Cimarelli, A. (2009). Characterization of the Behavior of Functional Viral Genomes during the Early Steps of Human Immunodeficiency Virus Type 1 Infection. J. Virol. 83: 7524-7535 [Abstract] [Full Text]  
  • Vatakis, D. N., Kim, S., Kim, N., Chow, S. A., Zack, J. A. (2009). Human Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent CD4+ T Cells. J. Virol. 83: 6222-6233 [Abstract] [Full Text]  
  • Nishimura, Y., Sadjadpour, R., Mattapallil, J. J., Igarashi, T., Lee, W., Buckler-White, A., Roederer, M., Chun, T.-W., Martin, M. A. (2009). High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections. Proc. Natl. Acad. Sci. USA 106: 8015-8020 [Abstract] [Full Text]  
  • Vatakis, D. N., Nixon, C. C., Bristol, G., Zack, J. A. (2009). Differentially Stimulated CD4+ T Cells Display Altered Human Immunodeficiency Virus Infection Kinetics: Implications for the Efficacy of Antiviral Agents. J. Virol. 83: 3374-3378 [Abstract] [Full Text]  
  • Frecha, C., Costa, C., Negre, D., Gauthier, E., Russell, S. J., Cosset, F.-L., Verhoeyen, E. (2008). Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. Blood 112: 4843-4852 [Abstract] [Full Text]  
  • Garcia, M., Yu, X.-F., Griffin, D. E., Moss, W. J. (2008). Measles virus inhibits human immunodeficiency virus type 1 reverse transcription and replication by blocking cell-cycle progression of CD4+ T lymphocytes. J. Gen. Virol. 89: 984-993 [Abstract] [Full Text]  
  • King, S. R., Duggal, N. K., Ndongmo, C. B., Pacut, C., Telesnitsky, A. (2008). Pseudodiploid Genome Organization Aids Full-Length Human Immunodeficiency Virus Type 1 DNA Synthesis. J. Virol. 82: 2376-2384 [Abstract] [Full Text]  
  • Plesa, G., Dai, J., Baytop, C., Riley, J. L., June, C. H., O'Doherty, U. (2007). Addition of Deoxynucleosides Enhances Human Immunodeficiency Virus Type 1 Integration and 2LTR Formation in Resting CD4+ T Cells. J. Virol. 81: 13938-13942 [Abstract] [Full Text]  
  • Munk, C., Zielonka, J., Constabel, H., Kloke, B.-P., Rengstl, B., Battenberg, M., Bonci, F., Pistello, M., Lochelt, M., Cichutek, K. (2007). Multiple Restrictions of Human Immunodeficiency Virus Type 1 in Feline Cells. J. Virol. 81: 7048-7060 [Abstract] [Full Text]  
  • Vatakis, D. N., Bristol, G., Wilkinson, T. A., Chow, S. A., Zack, J. A. (2007). Immediate Activation Fails To Rescue Efficient Human Immunodeficiency Virus Replication in Quiescent CD4+ T Cells. J. Virol. 81: 3574-3582 [Abstract] [Full Text]  
  • Oswald-Richter, K., Torres, V. J., Sundrud, M. S., VanCompernolle, S. E., Cover, T. L., Unutmaz, D. (2006). Helicobacter pylori VacA Toxin Inhibits Human Immunodeficiency Virus Infection of Primary Human T Cells. J. Virol. 80: 11767-11775 [Abstract] [Full Text]  
  • Chen, B., Nelson, D. M., Sadovsky, Y. (2006). N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury. J. Biol. Chem. 281: 2764-2772 [Abstract] [Full Text]  
  • Swiggard, W. J., Baytop, C., Yu, J. J., Dai, J., Li, C., Schretzenmair, R., Theodosopoulos, T., O'Doherty, U. (2005). Human Immunodeficiency Virus Type 1 Can Establish Latent Infection in Resting CD4+ T Cells in the Absence of Activating Stimuli. J. Virol. 79: 14179-14188 [Abstract] [Full Text]  
  • Monie, D., Simmons, R. P., Nettles, R. E., Kieffer, T. L., Zhou, Y., Zhang, H., Karmon, S., Ingersoll, R., Chadwick, K., Zhang, H., Margolick, J. B., Quinn, T. C., Ray, S. C., Wind-Rotolo, M., Miller, M., Persaud, D., Siliciano, R. F. (2005). A Novel Assay Allows Genotyping of the Latent Reservoir for Human Immunodeficiency Virus Type 1 in the Resting CD4+ T Cells of Viremic Patients. J. Virol. 79: 5185-5202 [Abstract] [Full Text]  
  • Zhou, Y., Zhang, H., Siliciano, J. D., Siliciano, R. F. (2005). Kinetics of Human Immunodeficiency Virus Type 1 Decay following Entry into Resting CD4+ T Cells. J. Virol. 79: 2199-2210 [Abstract] [Full Text]  
  • Consiglio, A., Gritti, A., Dolcetta, D., Follenzi, A., Bordignon, C., Gage, F. H., Vescovi, A. L., Naldini, L. (2004). From the Cover: Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101: 14835-14840 [Abstract] [Full Text]  
  • Han, Y., Lassen, K., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F., Siliciano, J. D. (2004). Resting CD4+ T Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals Carry Integrated HIV-1 Genomes within Actively Transcribed Host Genes. J. Virol. 78: 6122-6133 [Abstract] [Full Text]  
  • Triques, K., Stevenson, M. (2004). Characterization of Restrictions to Human Immunodeficiency Virus Type 1 Infection of Monocytes. J. Virol. 78: 5523-5527 [Abstract] [Full Text]  
  • Trobridge, G., Russell, D. W. (2004). Cell Cycle Requirements for Transduction by Foamy Virus Vectors Compared to Those of Oncovirus and Lentivirus Vectors. J. Virol. 78: 2327-2335 [Abstract] [Full Text]  
  • Wu, Y., Marsh, J. W. (2003). Early Transcription from Nonintegrated DNA in Human Immunodeficiency Virus Infection. J. Virol. 77: 10376-10382 [Abstract] [Full Text]  
  • Cavalieri, S., Cazzaniga, S., Geuna, M., Magnani, Z., Bordignon, C., Naldini, L., Bonini, C. (2003). Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 102: 497-505 [Abstract] [Full Text]  
  • O'Doherty, U., Swiggard, W. J., Jeyakumar, D., McGain, D., Malim, M. H. (2002). A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration. J. Virol. 76: 10942-10950 [Abstract] [Full Text]  
  • Ducrey-Rundquist, O., Guyader, M., Trono, D. (2002). Modalities of Interleukin-7-Induced Human Immunodeficiency Virus Permissiveness in Quiescent T Lymphocytes. J. Virol. 76: 9103-9111 [Abstract] [Full Text]  
  • Ruff, C. T., Ray, S. C., Kwon, P., Zinn, R., Pendleton, A., Hutton, N., Ashworth, R., Gange, S., Quinn, T. C., Siliciano, R. F., Persaud, D. (2002). Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral Exposure. J. Virol. 76: 9481-9492 [Abstract] [Full Text]  
  • Pierson, T. C., Zhou, Y., Kieffer, T. L., Ruff, C. T., Buck, C., Siliciano, R. F. (2002). Molecular Characterization of Preintegration Latency in Human Immunodeficiency Virus Type 1 Infection. J. Virol. 76: 8518-8531 [Abstract] [Full Text]  
  • Katz, R. A., Greger, J. G., Darby, K., Boimel, P., Rall, G. F., Skalka, A. M. (2002). Transduction of Interphase Cells by Avian Sarcoma Virus. J. Virol. 76: 5422-5434 [Abstract] [Full Text]  
  • Maurice, M., Verhoeyen, E., Salmon, P., Trono, D., Russell, S. J., Cosset, F.-L. (2002). Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide. Blood 99: 2342-2350 [Abstract] [Full Text]  
  • Kuhn, U., Terunuma, A., Pfutzner, W., Foster, R. A., Vogel, J. C. (2002). In Vivo Assessment of Gene Delivery to Keratinocytes by Lentiviral Vectors. J. Virol. 76: 1496-1504 [Abstract] [Full Text]  
  • Bell, P., Montaner, L. J., Maul, G. G. (2001). Accumulation and Intranuclear Distribution of Unintegrated Human Immunodeficiency Virus Type 1 DNA. J. Virol. 75: 7683-7691 [Abstract] [Full Text]  
  • McKnight, A., Griffiths, D. J., Dittmar, M., Clapham, P., Thomas, E. (2001). Characterization of a Late Entry Event in the Replication Cycle of Human Immunodeficiency Virus Type 2. J. Virol. 75: 6914-6922 [Abstract] [Full Text]  
  • Neil, S., Martin, F., Ikeda, Y., Collins, M. (2001). Postentry Restriction to Human Immunodeficiency Virus-Based Vector Transduction in Human Monocytes. J. Virol. 75: 5448-5456 [Abstract] [Full Text]  
  • Mikkola, H., Woods, N.-B., Sjögren, M., Helgadottir, H., Hamaguchi, I., Jacobsen, S.-E., Trono, D., Karlsson, S. (2000). Lentivirus Gene Transfer in Murine Hematopoietic Progenitor Cells Is Compromised by a Delay in Proviral Integration and Results in Transduction Mosaicism and Heterogeneous Gene Expression in Progeny Cells. J. Virol. 74: 11911-11918 [Abstract] [Full Text]  
  • Clark, E., Santiago, F., Deng, L., Chong, S. y., de la Fuente, C., Wang, L., Fu, P., Stein, D., Denny, T., Lanka, V., Mozafari, F., Okamoto, T., Kashanchi, F. (2000). Loss of G1/S Checkpoint in Human Immunodeficiency Virus Type 1-Infected Cells Is Associated with a Lack of Cyclin-Dependent Kinase Inhibitor p21/Waf1. J. Virol. 74: 5040-5052 [Abstract] [Full Text]